Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K A Charles

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The American Psychologist|November 1, 1984
The psychological impact of AIDS on gay menS F Morin, K A Charles, A K Malyon
British Journal of Cancer|March 31, 2011
Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancerW Chua, K A Charles, V E Baracos, et al.
Clinical Pharmacology and Therapeutics|February 12, 2010
Inflammation and cancer: causes and consequencesM M Moore, W Chua, K A Charles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2008
A clinical study assessing the tolerability and biological effects of infliximab, a TNF-alpha inhibitor, in patients with advanced cancerE R Brown, K A Charles, S A Hoare, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The American Psychologist|November 1, 1984
The psychological impact of AIDS on gay menS F Morin, K A Charles, A K Malyon
British Journal of Cancer|March 31, 2011
Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancerW Chua, K A Charles, V E Baracos, et al.
Clinical Pharmacology and Therapeutics|February 12, 2010
Inflammation and cancer: causes and consequencesM M Moore, W Chua, K A Charles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2008
A clinical study assessing the tolerability and biological effects of infliximab, a TNF-alpha inhibitor, in patients with advanced cancerE R Brown, K A Charles, S A Hoare, et al.
Pageof 1